Annexon Biosciences

Last updated: October 12, 2024

Douglas Love, CEO
Douglas Love, CEO
USA | Funding: $634M (+)

Website: http://www.annexonbio.com

Annexon Biosciences a biotechnology company, discovers and developing novel therapeutics for neurodegenerative and autoimmune disorders.